OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the stylized wording "PROVEPHARM" in dark blue with the letters "V" and "A" in light blue with the "A" missing the bar. The stylized wording "ACT TO IMPROVE LIFE" in light blue appears above "PHARM". An incomplete circle featuring various geometric shapes in various shades of light blue and dark blue starts above the letter "V" and continues below the "V" to the bottom of the letter "A".
Titulares
Representantes
Kaitlyn M. Garvin Saunders & Silverstein LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additives, namely, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agents, namely, enzyme stabilizers for vitamins
Classe 5
Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leg, hoof, ear, nose and throat for animals; vitamins for animals; medicated foams, oils, lotions, creams, balms, ointments, gels and milks for the treatment of skin for pharmaceutical, medical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical products, namely, surgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceutical, namely, surgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutions, namely, surgical dyes for medical use; indigo carmine, namely, surgical dyes for medical use; indigo cumin solutions, namely, surgical dyes for medical use
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/07/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/07/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2026
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2026
FINAL DISPOSITION PROCESSED
01/05/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/01/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/10/2025
REGISTERED-PRINCIPAL REGISTER
21/10/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2025
PUBLISHED FOR OPPOSITION
02/09/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/08/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
29/07/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2025
REFUSAL PROCESSED BY IB
05/07/2025
ASSIGNED TO LIE
23/06/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/06/2025
REFUSAL PROCESSED BY MPU
14/06/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/04/2025
NON-FINAL ACTION WRITTEN
14/04/2025
ASSIGNED TO EXAMINER
09/04/2025
APPLICATION FILING RECEIPT MAILED
28/02/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/02/2025
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/02/2025
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.